EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sustainability Assessment in Recombinant Human Insulin Production—Evaluating the Environmental Impacts of Microbial Growth Medium Components and Formulations

Konstantina-Roxani Chatzipanagiotou, Athanasios Pappas, Foteini Petrakli, George Antonaropoulos, Elias P. Koumoulos

Journal of Experimental and Theoretical Analyses · 15.09.2025 · 3 (3) · 28

DOI: 10.3390/jeta3030028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental and Theoretical Analyses, online erschienen am 15.09.2025. Verfasst von Konstantina-Roxani Chatzipanagiotou und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union’s Horizon 2020 research and innovation programme ENVIROMED: “ENVIROMED—Next generation toolbox for greener pharmaceuticals design & manufact….

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

According to the International Diabetes Federation, approximately 537 million adults suffered from diabetes in 2021, a number that is projected to rise to 783 million by 2045. Insulin is a hormone produced by the pancreas that regulates blood glucose levels; for people suffering from diabetes, insulin activity may be reduced or absent, and therefore, administration of insulin may be necessary to maintain healthy blood glucose levels. Recombinant human insulin is commercially produced using a variety of host microorganisms, such as bacteria and yeast. Nevertheless, few studies have assessed the environmental impacts associated with different upstream medium formulations and their contribution to the overall environmental footprint of recombinant insulin production. Here, Life Cycle Assessment (LCA) is conducted on various upstream media used in insulin production—including pre-cultivation, growth, feed, and induction media—capturing the impacts associated with both their supply chains and their on-site preparation. Hotspots of environmental impacts are identified, and different alternatives for input materials and process conditions are compared in terms of impacts. The findings reported here can serve to guide process and sustainability optimization of the upstream production process from an operational process perspective. Finally, the identification of hotspots enables the implementation of impact reduction measures in bioprocess design, which have the potential to significantly improve the sustainability of insulin production.

Förderung

  • European Union’s Horizon 2020 research and innovation programme ENVIROMED: “ENVIROMED—Next generation toolbox for greener pharmaceuticals design & manufact…

Zitieren

APA

Chatzipanagiotou, K., Pappas, A., Petrakli, F., Antonaropoulos, G., & Koumoulos, E. P. (2025). Sustainability Assessment in Recombinant Human Insulin Production—Evaluating the Environmental Impacts of Microbial Growth Medium Components and Formulations. Journal of Experimental and Theoretical Analyses, 3(3), 28. https://doi.org/10.3390/jeta3030028

Vancouver

Chatzipanagiotou K, Pappas A, Petrakli F, Antonaropoulos G, Koumoulos EP. Sustainability Assessment in Recombinant Human Insulin Production—Evaluating the Environmental Impacts of Microbial Growth Medium Components and Formulations. Journal of Experimental and Theoretical Analyses. 2025;3(3):28. doi:10.3390/jeta3030028

BibTeX
@article{Chatzipanagiotou2025,
  author = {Chatzipanagiotou, Konstantina-Roxani and Pappas, Athanasios and Petrakli, Foteini and Antonaropoulos, George and Koumoulos, Elias P.},
  title = {Sustainability Assessment in Recombinant Human Insulin Production—Evaluating the Environmental Impacts of Microbial Growth Medium Components and Formulations},
  journal = {Journal of Experimental and Theoretical Analyses},
  year = {2025},
  volume = {3},
  number = {3},
  pages = {28},
  doi = {10.3390/jeta3030028}
}
Kostenlos starten →